← FDA Drug Approvals (Drugs@FDA)

ITOVEBI

NDA · New Drug Application · Sponsor: GENENTECH INC · Approved 2024-10-10

Drug application

FDA Application #

NDA219249

Application type

New Drug Application

Brand name

ITOVEBI

Generic name

INAVOLISIB

Active ingredients

INAVOLISIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GENENTECH INC

Manufacturer

Genentech, Inc.

First approval

2024-10-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown